Aurelie Sadoux

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma.

Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma.

Journal: EMBO molecular medicine

Published: October 26, 2024

Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.

Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.

Journal: Melanoma research

Published: December 23, 2023

Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high-throughput sequencing approach.

Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high-throughput sequencing approach.

Journal: The British journal of dermatology

Published: December 13, 2023

Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.

Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.

Journal: Oncogene

Published: May 30, 2023

Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides.

Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides.

Journal: The British journal of dermatology

Published: December 10, 2021

Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series.

Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 15, 2021

Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.

Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.

Journal: Blood

Published: July 13, 2021

Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma.

Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma.

Journal: The British journal of dermatology

Published: March 12, 2021

Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction.

Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction.

Journal: Oncogene

Published: March 12, 2021

A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping.

A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping.

Journal: Targeted oncology

Published: November 05, 2020

Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism.

Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 30, 2020

Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome.

Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome.

Journal: The British journal of dermatology

Published: September 15, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026